Zealand Pharma A/S (ZLDPF PINK) stock market data APIs
$80.3673
0.2(0.2%)
as of December 5, 2025
Try our APIs with
free plan!
Zealand Pharma A/S Financial Data Overview
Price chart is built with
Anychart
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S was incorporated in 1997 and is based in Søborg, Denmark.
Prev. Close
80.3673
Open
80.5673
High
80.7431
Low
80.1835
52 wk Range
49.98-114.72
Market Cap
5 743 M
P/E Ratio
5.6079
Shares Outstanding
70 287 K
Revenue
9 155 M
EPS
-0.9003
Beta
0.545
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Zealand Pharma A/S data using free add-ons & libraries
Get Zealand Pharma A/S Fundamental Data
Zealand Pharma A/S Fundamental data includes:
- Net Revenue: 9 155 M
- EBITDA: 7 081 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-13
- EPS/Forecast: -7.72
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Zealand Pharma A/S News
New
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma Company announcement – No. 24 / 2025 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associat...
REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025
Zealand Pharma Press release – No. 17 / 2025 REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025 Copenhagen, Denmark, December 1, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-n...
Short Bowel Syndrome Market to Register Stunning Growth at a CAGR of 5% During the Forecast Period (2025-2034) Owing to the Launch of Novel GLP-2 Analogues | DelveInsight
The short bowel syndrome market is poised for significant change, with next-generation GLP-2 analogues such as apraglutide (Ironwood Pharmaceuticals), glepaglutide (Zealand Pharma), and sonefpeglutide...
Could Zealand Pharma’s (CPSE:ZEAL) Shift from Dapiglutide Reveal a New R&D Playbook?
Earlier this week, Zealand Pharma announced it is pausing development of its early-stage obesity drug dapiglutide due to the increasingly crowded GLP-1 weight loss market, refocusing efforts on other ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
